Cite
ABCC6 plays a significant role in the transport of nilotinib and dasatinib, and contributes to TKI resistance in vitro, in both cell lines and primary patient mononuclear cells.
MLA
Eadie, Laura N., et al. “ABCC6 Plays a Significant Role in the Transport of Nilotinib and Dasatinib, and Contributes to TKI Resistance in Vitro, in Both Cell Lines and Primary Patient Mononuclear Cells.” PLoS ONE, vol. 13, no. 1, Jan. 2018, pp. 1–18. EBSCOhost, https://doi.org/10.1371/journal.pone.0192180.
APA
Eadie, L. N., Dang, P., Goyne, J. M., Hughes, T. P., & White, D. L. (2018). ABCC6 plays a significant role in the transport of nilotinib and dasatinib, and contributes to TKI resistance in vitro, in both cell lines and primary patient mononuclear cells. PLoS ONE, 13(1), 1–18. https://doi.org/10.1371/journal.pone.0192180
Chicago
Eadie, Laura N., Phuong Dang, Jarrad M. Goyne, Timothy P. Hughes, and Deborah L. White. 2018. “ABCC6 Plays a Significant Role in the Transport of Nilotinib and Dasatinib, and Contributes to TKI Resistance in Vitro, in Both Cell Lines and Primary Patient Mononuclear Cells.” PLoS ONE 13 (1): 1–18. doi:10.1371/journal.pone.0192180.